Cyclacel Pharmaceuticals, Inc. (CYCC) Tops Q2 EPS by 8c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Super Micro Computer establishes $1.25 billion stock sale agreement
Form 10-Q Cyclacel Pharmaceuticals For: Jun 30
August 12, 2014 5:04 PM EDThttp://archive.fast-edgar.com/20140812/A422NQ2CZ226CZZ4222C2ZDZI3QUGZS2Z262 Filed on: August 12, 2014... More
Form 8-K Cyclacel Pharmaceuticals For: Aug 12
August 12, 2014 4:17 PM EDThttp://archive.fast-edgar.com/20140812/AW2X9Q2CZ226WZZ4222C2ZDZOUWEZZR2Z262 Filed on: August 12, 2014... More
